3-iodobenzylguanidine has been researched along with labetalol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Brockmöller, J; Dücker, C; Jensen, O | 1 |
| Boutelant, S; de Gaudemaris, R; Fagret, D; Mallion, JM; Schwebel, C; Siché, JP; Tremel, F | 1 |
| Bardies, M; Chatal, JF; Chetanneau, A; Kremer, M; Le Marec, H; Morais, J; Peltier, P | 1 |
| Fig, LM; Khafagi, FA; Mallette, S; Shapiro, B; Sisson, JC | 1 |
| Apeldoorn, L; Hoefnagel, CA; Voerman, HJ | 1 |
| Plowman, PN | 1 |
| Jacobson, AF; Travin, MI | 1 |
1 review(s) available for 3-iodobenzylguanidine and labetalol
| Article | Year |
|---|---|
Impact of medications on mIBG uptake, with specific attention to the heart: Comprehensive review of the literature.
Topics: 3-Iodobenzylguanidine; Amines; Amiodarone; Animals; Anti-Arrhythmia Agents; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Cardiology; Cell Line; Cell Line, Tumor; Diagnostic Imaging; Drug Interactions; Heart; Heart Failure; Humans; Iodine Radioisotopes; Labetalol; Norepinephrine; Radiopharmaceuticals; Receptors, Adrenergic; Reproducibility of Results; Reserpine; Risk; Selective Serotonin Reuptake Inhibitors; Sympathetic Nervous System | 2015 |
6 other study(ies) available for 3-iodobenzylguanidine and labetalol
| Article | Year |
|---|---|
Identification of Novel High-Affinity Substrates of OCT1 Using Machine Learning-Guided Virtual Screening and Experimental Validation.
Topics: Databases, Chemical; Drug Evaluation, Preclinical; HEK293 Cells; Humans; Machine Learning; Octamer Transcription Factor-1; Organic Chemicals | 2021 |
[Action of labetalol on norepinephrine myocardial content in left ventricular hypertrophy in hypertensive patients].
Topics: 3-Iodobenzylguanidine; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Iodine Radioisotopes; Iodobenzenes; Labetalol; Male; Myocardium; Norepinephrine; Radionuclide Imaging; Sympathetic Nervous System | 1992 |
MIBG scintigraphy of a patient with pheochromocytoma on labetalol therapy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Humans; Iodine Radioisotopes; Iodobenzenes; Labetalol; Male; Pheochromocytoma; Radionuclide Imaging | 1992 |
Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Drug Interactions; False Negative Reactions; False Positive Reactions; Female; Humans; Hypertension; Iodine Radioisotopes; Iodobenzenes; Labetalol; Liver; Male; Middle Aged; Pheochromocytoma; Salivary Glands; Spleen; Sympatholytics | 1989 |
Interference of MIBG uptake by medication: a case report.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Contrast Media; Diagnosis, Differential; Drug Interactions; Humans; Hypertension; Iodine Radioisotopes; Iodobenzenes; Labetalol; Male; Middle Aged; Pheochromocytoma; Radionuclide Imaging | 1995 |
Positive MIBG scanning at the time of relapse in neuroblastoma which was MIBG negative at diagnosis.
Topics: 3-Iodobenzylguanidine; Antihypertensive Agents; Drug Interactions; False Negative Reactions; Humans; Kidney Neoplasms; Labetalol; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Recurrence | 1997 |